Get started
VISTIN PHARMA ASAVISTIN PHARMA ASAVISTIN PHARMA ASA

VISTIN PHARMA ASA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

VISTN chart


Full chart

Key stats


Market capitalization
‪1.06 B‬ NOK
Dividend yield (indicated)
5.21%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
1.4 NOK
Net income (FY)
‪62.75 M‬ NOK
Revenue (FY)
‪429.50 M‬ NOK
Shares float
‪20.88 M‬
Beta (1Y)
0.12

Employees


Employees (FY)
170
Change (1Y)
+93 +120.78%
Revenue / Employee (1Y)
‪2.53 M‬ NOK
Net income / Employee (1Y)
‪369.14 K‬ NOK

About VISTIN PHARMA ASA


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Magnus Tolleshaug
Website
vistin.com
Headquarters
Oslo
Founded
2015
ISIN
NO0010734122
FIGI
BBG00N0NQX07
Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). It offers Metformin HCI and Metformin DC. The company was founded on March 6, 2015 and is headquartered in Oslo, Norway.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

VISTN news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as VISTN.

Frequently Asked Questions


The current price of VISTN is 24.0 NOK — it has increased by 4.35% in the past 24 hours. Watch VISTIN PHARMA ASA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange VISTIN PHARMA ASA stocks are traded under the ticker VISTN.
VISTN stock hasn't changed in a week, the month change is a 0.84% rise, over the last year there was no change in VISTIN PHARMA ASA price.
VISTN reached its all-time high on Apr 12, 2021 with the price of 29.5 NOK, and its all-time low was 5.0 NOK and was reached on Mar 12, 2020. View more price dynamics on VISTN chart.
See other stocks reaching their highest and lowest prices.
VISTN stock is 4.31% volatile and has beta coefficient of 0.12. Track VISTIN PHARMA ASA stock price on the chart and check out the list of the most volatile stocks — is VISTIN PHARMA ASA there?
Yes, you can track VISTIN PHARMA ASA financials in yearly and quarterly reports right on TradingView.
VISTN net income for the last quarter is ‪19.37 M‬ NOK, while the quarter before that showed ‪16.57 M‬ NOK of net income which accounts for 16.93% change. Track more VISTIN PHARMA ASA financial stats to get the full picture.
Yes, VISTN dividends are paid annually. The last dividend per share was 0.50 NOK. As of today, Dividend Yield (TTM)% is 4.17%. Tracking VISTIN PHARMA ASA dividends might help you take more informed decisions.
As of Apr 19, 2025, the company has 170 employees. See our rating of the largest employees — is VISTIN PHARMA ASA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VISTIN PHARMA ASA EBITDA is ‪104.33 M‬ NOK, and current EBITDA margin is 24.29%. See more stats in VISTIN PHARMA ASA financial statements.
Like other stocks, VISTN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VISTIN PHARMA ASA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VISTIN PHARMA ASA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VISTIN PHARMA ASA stock shows the buy signal. See more of VISTIN PHARMA ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.